Multi-sectoral Collaboration Helps Raw Materials "Pass" Peak Healthy A Batch of Imported Raw Materials Arrives from Shanghai
Release time:
2022-06-13
News from our newspaper 5# March 26 , a batch of cranberry raw materials imported by Jianfeng Health Technology Company finally successfully arrived at the workshop after 3 months of hard work and cooperation. This batch of cranberry raw materials has experienced many twists and turns from the beginning of purchase. Spike health procurement staff to search, after several months to find a standard supply. Imports from Canada arrive at Shanghai port at the end of 3 and can be received at the beginning of
4according to plan. Due to the severe epidemic situation in Shanghai and cranberry raw materials for frozen transportation, local control is strict, the need for layer-by-layer killing and nucleic acid testing. In order to ensure that cranberry transportation and production meet the control requirements, Jianfeng Health invited professionals from the Economic and Commercial Bureau to train relevant personnel in the enterprise and formulated a transportation and production plan for imported goods as required. When applying for transportation, it happened to encounter the outbreak of Jinhua epidemic, the goods can only be stranded in Shanghai. 5 17 , Jianfeng Health once again applied to the District Economic and Commercial Bureau for the transportation of imported goods. After approval, it started the cranberry raw material transportation and production plan. During the transportation of raw materials, the various departments of Peak Health will act separately. The purchasing personnel will contact Shanghai Port for preventive killing and nucleic acid testing, and arrange the drivers to do nucleic acid testing. The Comprehensive Finance Department shall contact the Economic and Commercial Bureau, the township government and the Transportation Bureau to report the transportation vehicle information and apply for the transportation vehicle to pass through the high-speed bayonet. Anhuanke contacted the killing company and the nucleic acid sampling company to prepare for the killing of transport vehicles and goods and nucleic acid sampling and testing. After multi-party coordination, the Shanghai brand truck responsible for transporting frozen cranberries passed through the high-speed bayonet smoothly. The peak health related personnel received the truck at the high-speed bayonet, led the truck to the designated place to complete the dual-core test of the driver, sealed the door, and led the truck to the factory. The personnel of both sides had zero contact in the whole process.
Raw materials arrive at the factory, unloading and storage need closed-loop management. The truck was killed by a third-party killing company and drove to the designated area to prepare for unloading. The warning line was pulled up and signs were placed to indicate not to approach at will. Since the loading and unloading personnel need to control7 days, only as few people can participate in unloading. From
5p. m. to 12 p. m., the three employees involved in unloading were sweating like a pig in the truck at minus 35 18 degrees. After unloading is completed, the elimination company shall eliminate the cargo, vehicles, loading and unloading areas and storage areas, nucleic acid sampling personnel shall sample the environment and cranberries, and the loading and unloading personnel shall conduct nucleic acid detection and cargo detection every 2 days. Due to the impact of the epidemic, the procurement of imported raw materials is difficult. Through the efforts of various departments, the procurement has been completed, which has accumulated valuable experience for the handling of similar situations. This batch of goods has been officially put into production after meeting the time requirement of standing for 7 days. (Zhao Chunquan Chen Yueping)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page